Behavioral Activation for the Prevention and Treatment of Depression in Older Adults in a Municipal Context
DePrevent
1 other identifier
interventional
160
1 country
1
Brief Summary
The goal of this randomized clinical trial is to investigate if a brief psychological treatment called Behavioral Activation (BA) works to prevent and treat depression in older adults in a municipal context in Sweden. It will also learn about the patients' and therapists' experiences of the BA-treatment. The main questions it aims to answer are if the BA-treatment has an effect on the short and long term on:
- Depressive symptoms
- Anxiety symptoms
- Self-rated activation
- Functional ability
- Loneliness
- Self efficacy
- Mental wellbeing
- Quality of life
- Need for community care services All participants will continue their care as usual (CAU), and half of the participants will be randomized to receive a five-session BA-treatment spread over two months as an add-on to CAU. All participants will answer a questionnaire in the beginning of the study, after two months, and after 3-, 6- and 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Jun 2024
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2024
CompletedFirst Posted
Study publicly available on registry
May 16, 2024
CompletedStudy Start
First participant enrolled
June 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
ExpectedDecember 16, 2024
December 1, 2024
1.4 years
May 7, 2024
December 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Montgomery-Åsberg Depression Rating Scale, MADRS-S
Depressive symptoms will be measured with the Montgomery-Åsberg Depression Rating Self-rating Scale (MADRS-S). The MADRS-S is a nine-item questionnaire designed to measure depression severity during the past two weeks. The total score ranges from 0-54, with higher scores indicating higher depression severity.
Baseline; post-intervention or equivalent for control group 9 weeks after baseline; 3-, 6- and 12 months post-intervention or equivalent for control group
Secondary Outcomes (9)
Geriatric Depression Scale 15, GDS-15
Baseline; post-intervention or equivalent for control group 9 weeks after baseline; 3-, 6- and 12 months post-intervention or equivalent for control group
Geriatric Anxiety Scale 10, GAS-10
Baseline; post-intervention or equivalent for control group 9 weeks after baseline; 3-, 6- and 12 months post-intervention or equivalent for control group
WHO disability assessment schedule 12-item, WHODAS-12
Baseline; post-intervention or equivalent for control group 9 weeks after baseline; 3-, 6- and 12 months post-intervention or equivalent for control group
Behavioral activation for depression scale - short form, BADS-SF
Baseline; post-intervention or equivalent for control group 9 weeks after baseline; 3-, 6- and 12 months post-intervention or equivalent for control group
UCLA Loneliness Scale version 3, UCLA-LS 3
Baseline; post-intervention or equivalent for control group 9 weeks after baseline; 3-, 6- and 12 months post-intervention or equivalent for control group
- +4 more secondary outcomes
Study Arms (2)
Brief Behavioral Activation plus Care as Usual
EXPERIMENTALFive-session Brief Behavioral Activation intervention. Sessions 1 - 4 are completed once a week, and session 5 is a booster-session completed four weeks after session 4.
Care as Usual
ACTIVE COMPARATORCare as usual as provided by primary care and/or municipal care.
Interventions
A five-session brief behavioral activation treatment delivered face-to-face in the participants' home. Session outline: Session 1: Psychoeducation about depression; treatment rationale for Behavioral Activation (BA); rationale and instructions for activity log Session 2: Discussion of life goals and values; planning of activities aligned with life goals and values for coming week Session 3: Troubleshooting any problems carrying out activities; planning activities aligned with life goals and values for coming week. Session 4: Troubleshooting any problems carrying out activities; planning activities aligned with life goals and values for the coming week; instructing the participant to independently continue to plan activities for the coming month. Session 5: Troubleshooting any problems carrying out activities; reviewing treatment; stressing the importance of continuing to engage in activities aligned with life goals and values; creating a maintenance plan.
Care as Usual provided by primary care and/or municipal care.
Eligibility Criteria
You may qualify if:
- years or older
- points or above on the Geriatric Depression Scale 15, GDS-15
- Fluent in written and spoken Swedish
- Consents to participate in the trial
You may not qualify if:
- Not able to use the patient materials due to visual impairment
- Not able to communicate with therapist due to hearing impairment
- Diagnosis of major neurocognitive disorder
- Below 25 points on the Mini Mental State Examination, MMSE
- Elevated suicide risk
- Current substance- or alcohol use disorder
- Previous or current psychotic disorder
- Previous or current bipolar disorder
- Ongoing psychological treatment/pscyhotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sormland County Council, Swedenlead
- Eskilstuna municipalitycollaborator
Study Sites (1)
Eskilstuna kommun
Eskilstuna, Sörmland, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Johnny Pellas, PhD
Research and Development Sormland
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2024
First Posted
May 16, 2024
Study Start
June 27, 2024
Primary Completion
December 1, 2025
Study Completion (Estimated)
August 1, 2026
Last Updated
December 16, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Study protocol and statistical analysis plan to be shared/published before data collection has ended.